C vs TECH
Citigroup Inc. (C) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
C currently screens at market cap $214.73B and trailing P/E 15.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the C and TECH stock pages for the full models.
Not investment advice.